Abstract
A variety of delivery vehicles have been explored as adjuvanting/delivery platforms for peptide-based subunit vaccines. Polysaccharide-based systems have been found to be especially attractive due to their immune stimulating properties, biodegradability, biocompatibility, and low toxicity. Among them, chitosan and its derivatives are the most common cationic nanocarriers used for the delivery of antigens. Trimethyl chitosan (TMC) is a partially quaternized, water-soluble, and mucoadhesive derivative of chitosan. This chapter describes the preparation of a TMC-based polyelectrolyte complex as a delivery system for peptide subunit vaccines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nevagi RJ, Toth I, Skwarczynski M (2018) Peptide-based vaccines. In: Koutsopoulos S (ed) Peptide applications in biomedicine, biotechnology and bioengineering. Woodhead Publishing, Oxford
Skwarczynski M, Toth I (2016) Peptide-based synthetic vaccines. Chem Sci 7(2):842–854
Bartlett S, Skwarczynski M, Toth I (2020) Lipids as activators of innate immunity in peptide vaccine delivery. Curr Med Chem 27(17):2887–2901
Nevagi RJ, Skwarczynski M, Toth I (2019) Polymers for subunit vaccine delivery. Eur Polym J 114:397–410
Fujita Y, Taguchi H (2011) Current status of multiple antigen-presenting peptide vaccine systems: application of organic and inorganic nanoparticles. Chem Cent J 5(1):48
Skwarczynski M, Toth I (2014) Recent advances in peptide-based subunit nanovaccines. Nanomedicine 9:2657–2669
Reddy ST, Van Der Vlies AJ, Simeoni E et al (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25(10):1159–1164
Henriksen-Lacey M, Christensen D, Bramwell VW et al (2011) Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention. Mol Pharm 8(1):153–161
Yang JR, Luo YC, Shibu MA et al (2019) Cell-penetrating peptides: efficient vectors for vaccine delivery. Curr Drug Deliv 16(5):430–443
Hussein WM, Liu TY, Skwarczynski M et al (2014) Toll-like receptor agonists: a patent review (2011 - 2013). Expert Opin Ther Pat 24(4):453–470
Zheng J, Gao S, Cui X et al (2019) Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines. Int J Pharm 572:118731
Marasini N, Skwarczynski M, Toth I (2017) Intranasal delivery of nanoparticle-based vaccines. Ther Deliv 8(3):151–167
Malonis RJ, Lai JR, Vergnolle O (2020) Peptide-based vaccines: current progress and future challenges. Chem Rev 120(6):3210–3229
Sedaghat B, Stephenson R, Toth I (2014) Targeting the mannose receptor with mannosylated subunit vaccines. Curr Med Chem 21(30):3405–3418
Li P, Wang F (2015) Polysaccharides: candidates of promising vaccine adjuvants. Drug Discov Ther 9(2):88–93
Zhao L, Skwarczynski M, Toth I (2019) Polyelectrolyte-based platforms for the delivery of peptides and proteins. ACS Biomater Sci Eng 5(10):4937–4950
Meka VS, Sing MKG, Pichika MR et al (2017) A comprehensive review on polyelectrolyte complexes. Drug Discov Today 22(11):1697–1706
Li X, Min M, Du N et al (2013) Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine. Clin Dev Immunol 2013:387023
Nevagi RJ, Dai W, Khalil ZG et al (2019) Structure-activity relationship of group a streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system. Eur J Med Chem 179:100–108
Marasini N, Ghaffar KA, Giddam AK et al (2017) Highly immunogenic trimethyl chitosan-based delivery system for intranasal lipopeptide vaccines against Group A Streptococcus. Curr Drug Deliv 14(5):701–708
Jeong Y, Lee D, Choe K et al (2017) Polypeptide-based polyelectrolyte complexes overcoming the biological barriers of oral insulin delivery. J Indust Eng Chem 48:79–87
Zhao L, Jin W, Cruz JG et al (2020) Development of polyelectrolyte complexes for the delivery of peptide-based subunit vaccines against group A Streptococcus. Nanomaterials (Basel) 10:823
Marasini N, Giddam AK, Ghaffar KA et al (2016) Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus. Nanomedicine 11(10):1223–1236
Polnok A, Borchard G, Verhoef JC et al (2004) Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm 57(1):77–83
Verheul RJ, Amidi M, Van Der Wal S et al (2008) Synthesis, characterization and in vitro biological properties of O-methyl free N,N,N-trimethylated chitosan. Biomaterials 29(27):3642–3649
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhao, L., Bashiri, S., Toth, I., Skwarczynski, M. (2022). Preparation of Trimethyl Chitosan-Based Polyelectrolyte Complexes for Peptide Subunit Vaccine Delivery. In: Bidmos, F., Bossé, J., Langford, P. (eds) Bacterial Vaccines. Methods in Molecular Biology, vol 2414. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1900-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1900-1_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1899-8
Online ISBN: 978-1-0716-1900-1
eBook Packages: Springer Protocols